Mairs & Power Inc Vericel Corp Transaction History

Mairs & Power Inc

$10.5 Billion
Q3 2024

A detailed history of Mairs & Power Inc transactions in Vericel Corp stock. As of the latest transaction made, Mairs & Power Inc holds 25,915 shares of VCEL stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,915

Previous 25,915 -0.0%

Holding current value

$1.52 Million

Previous $1.19 Million 7.91%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $1,450 - $1,918	-50 Reduced 0.19%	25,915 $973,000
Q1 2023 May 15, 2023	SELL	$23.85 - $31.34 $2,981 - $3,917	-125 Reduced 0.48%	25,965 $761,000
Q4 2022 Feb 14, 2023	SELL	$17.65 - $27.37 $7,059 - $10,948	-400 Reduced 1.51%	26,090 $687,000
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $10,616 - $14,502	-335 Reduced 1.25%	26,490 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $13,200 - $19,725	-375 Reduced 1.38%	26,825 $1.05 Million
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $23,638 - $30,472	-510 Reduced 1.84%	27,200 $1.33 Million
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $13,688 - $19,664	-290 Reduced 1.04%	27,710 $1.46 Million
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $15,465 - $29,740	-500 Reduced 1.75%	28,000 $1.56 Million
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $138,975 - $236,250	7,500 Added 35.71%	28,500 $880,000
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $151,470 - $211,200	11,000 Added 110.0%	21,000 $365,000
Q3 2019 Nov 14, 2019	BUY	$14.93 - $19.83 $149,300 - $198,299	10,000 New	10,000 $151,000

Others Institutions Holding VCEL

# of Institutions

279

Shares Held

48.7M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account